16 tracked fund houses held SUNPHARMA in Aug 2026. None entered or exited.
All tracked schemes together held 25.98 cr shares, 10.83% of equity, worth ₹51,478 cr at the end of Aug 2026.
Index and arbitrage funds held 3.65% of equity; they are left out of the fund-house counts.
Top buyer SBI Mutual Fund, +0.16% of equity. Top seller Aditya Birla Sun Life Mutual Fund, −0.07% of equity. Index and arbitrage funds hidden.
FPI category I + II, % of total shares · 1 named at 1% or more
FPIs named at 1% or more on 30 Jun 2026: Government Pension Fund Global 1.03%.
of promoter holding · 0.90% of total shares
Promoters had pledged 2.15 cr of their 130.71 cr shares on 30 Jun 2026; 2.15 cr encumbered in all (pledge, NDU and other).
percentile 73 of 30 days collected
51,956 shares, under 0.01% of equity in SLBS open positions at the end of 25 Sep 2026; that day sits at percentile 73 of 30 days collected. No SLBM trades in SUNPHARMA on 25 Sep 2026.
percentile 72 of 29 days collected · ₹274 cr financed
14.81 lakh shares, 0.06% of equity in the margin trading book at the end of 24 Sep 2026; that day sits at percentile 72 of 29 days collected.
20-day average 64.6% · percentile 23 of 30 days collected
59.0% of the shares traded on 25 Sep 2026 were delivered, against a 20-day average of 64.6%; that day sits at percentile 23 of 30 days collected.
MWPL used 9.9% on 25 Sep 2026 · ban above 95%, lifted below 80%
SUNPHARMA was not in the F&O ban period on 25 Sep 2026; 9.9% of its market-wide position limit was used on 25 Sep 2026. In the ban on 0 of 30 days collected. NSE listed SUNPHARMA under no ASM or GSM stage on 25 Sep 2026. Pledge invocations are not collected yet.